美股異動 | 美國航空(AAL.US)漲6.11% 預計第二季度營收將較2019年同期增長11%-13%
格隆匯7月12日丨美國航空(AAL.US)漲6.11%,報14.25美元。該公司週二表示,第二季度初步營收較2019同期將增長11%-13%。公司預計第二季度總可用座位里程數為66.2億英里,較2019年第二季度下降8.5%,此前提供的業績指引則為下降7%至8%。與2019年第二季度相比,每可用座位英里總營收(TRASM)預計將增長約22.5%,而該公司此前提供的業績指引為增長20% - 22%。與2019年第二季度相比,每座位里程成本(CASM)預計將增長約12%,而此前提供的業績指引為增長10% - 11%。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.